Atossa Therapeutics Inc (ATOS)
1.66
+0.14
(+9.21%)
USD |
NASDAQ |
May 03, 16:00
1.66
0.00 (0.00%)
Pre-Market: 20:00
Atossa Therapeutics 1 Year Total Returns (Daily): 150.6% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 150.6% |
May 02, 2024 | 137.5% |
May 01, 2024 | 155.0% |
April 30, 2024 | 136.2% |
April 29, 2024 | 139.4% |
April 26, 2024 | 153.1% |
April 25, 2024 | 139.4% |
April 24, 2024 | 123.2% |
April 23, 2024 | 112.9% |
April 22, 2024 | 102.9% |
April 19, 2024 | 83.99% |
April 18, 2024 | 89.33% |
April 17, 2024 | 82.43% |
April 16, 2024 | 109.5% |
April 15, 2024 | 132.7% |
April 12, 2024 | 130.2% |
April 11, 2024 | 139.2% |
April 10, 2024 | 148.1% |
April 09, 2024 | 154.0% |
April 08, 2024 | 141.6% |
April 05, 2024 | 161.8% |
April 04, 2024 | 193.1% |
April 03, 2024 | 170.0% |
April 02, 2024 | 153.8% |
April 01, 2024 | 175.9% |
Date | Value |
---|---|
March 28, 2024 | 162.8% |
March 27, 2024 | 177.2% |
March 26, 2024 | 158.5% |
March 25, 2024 | 171.4% |
March 22, 2024 | 133.2% |
March 21, 2024 | 151.7% |
March 20, 2024 | 148.9% |
March 19, 2024 | 124.6% |
March 18, 2024 | 86.96% |
March 15, 2024 | 98.46% |
March 14, 2024 | 80.18% |
March 13, 2024 | 93.85% |
March 12, 2024 | 94.13% |
March 11, 2024 | 77.83% |
March 08, 2024 | 53.52% |
March 07, 2024 | 52.78% |
March 06, 2024 | 59.72% |
March 05, 2024 | 42.12% |
March 04, 2024 | 42.12% |
March 01, 2024 | 36.56% |
February 29, 2024 | 32.03% |
February 28, 2024 | 35.14% |
February 27, 2024 | 34.98% |
February 26, 2024 | 31.43% |
February 23, 2024 | 32.34% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-86.06%
Minimum
Jun 28 2022
265.9%
Maximum
Mar 11 2021
3.28%
Average
-5.24%
Median
Sep 05 2019
1 Year Total Returns (Daily) Benchmarks
AngioDynamics Inc | -27.68% |
Achieve Life Sciences Inc | -45.13% |
Biolase Inc | -99.46% |
Outset Medical Inc | -84.54% |
Perspective Therapeutics Inc | 196.0% |